{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T19:23:31Z","timestamp":1794079411133,"version":"4.8.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000272","name":"DH | National Institute for Health Research","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Lung cancer screening with low-dose computed tomography has been proven to reduce lung-cancer-specific and all-cause mortality. The UK launched the NHS England Targeted Lung Health Check Programme in 2019, which has now become the national Lung Cancer Screening Programme, with full coverage expected by 2030. Here we present the progress and outcomes of the program. People aged 55\u201374 were offered low-dose computed tomography of the thorax if they had ever smoked and if risk thresholds, as determined by multivariable models, were met. Delivery of the program is through regionally federated clinical infrastructure and leadership, with national strategic, clinical and economic frameworks. The program has invited over two million people, with 7,193 lung cancers diagnosed\u201463.1% at tumor, node, metastasis stage 1 and 12.6% stage 2\u2014to March 2025. This has increased the early-stage proportion of lung cancer in England over 5 years, particularly in socioeconomically deprived regions. The NHS England Programme exemplifies how large-scale implementation can be achieved at speed through centralized protocols and effective project management. The program has demonstrated feasibility and scalability in reaching high-risk and underserved populations, but needs to further address inequalities in participation. These findings support adoption of lung cancer screening across the UK and globally, and offer practical tools for international adaptation.<\/jats:p>","DOI":"10.1038\/s41591-026-04292-y","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T10:02:37Z","timestamp":1774260157000},"page":"1817-1826","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Implementation of the NHS England Lung Cancer Screening Programme over 5 years"],"prefix":"10.1038","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8368-3406","authenticated-orcid":false,"given":"Richard W.","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjun","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haval","family":"Balata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Graham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4297-7808","authenticated-orcid":false,"given":"Craig","family":"Parylo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2125-2229","authenticated-orcid":false,"given":"Jessica","family":"Abell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Woodall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0389-4017","authenticated-orcid":false,"given":"Michael","family":"Lawrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Mouland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Brain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Crosbie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Devaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesme","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Grange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6634-5939","authenticated-orcid":false,"given":"Sam M.","family":"Janes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2306-4974","authenticated-orcid":false,"given":"Peter","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Mackie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6412-7516","authenticated-orcid":false,"given":"Neal","family":"Navani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha L.","family":"Quaife","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia","family":"Randle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9536-9809","authenticated-orcid":false,"given":"Janette","family":"Rawlinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3875-3780","authenticated-orcid":false,"given":"Robert C.","family":"Rintoul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liz","family":"Rochelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1509-8744","authenticated-orcid":false,"given":"Peter","family":"Sasieni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8157-0803","authenticated-orcid":false,"given":"Matthew E. J.","family":"Callister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8410-7160","authenticated-orcid":false,"given":"David R.","family":"Baldwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of UK Lung Cancer Screening Research Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellis","family":"Akhurst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asif","family":"Azam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thilan Rajith","family":"Bartholomeuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Baugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Bibby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Booton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Brindle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leanne","family":"Cheyne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyrus","family":"Daneshvar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhananjay","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer Lisa","family":"Dickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurnak Singh","family":"Dosanjh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Faccenda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth Ruth","family":"Fuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt Gabriel","family":"Gallardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sindy","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Graves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seamus","family":"Grundy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Hale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Hicks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Howells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Hume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Ledson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai En","family":"Low","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Mackinlay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afsar","family":"Madathil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkateswaran","family":"Mahadevan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"McMaster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"McSwiney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Messenger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peer Mohamad","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babu","family":"Naidu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kofi","family":"Nimako","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Page","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Poole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Powell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baiju Saradananda","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arvind","family":"Rajasekaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poppy","family":"Richards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabinder Singh","family":"Randhawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimuli","family":"Ryanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haarini","family":"Sridhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Uys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna C.","family":"Walsham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher James","family":"Warburton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Weatherhead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Windle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"key":"4292_CR1","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/S0140-6736(22)01694-4","volume":"401","author":"SJ Adams","year":"2023","unstructured":"Adams, S. J. et al. Lung cancer screening. Lancet 401, 390\u2013408 (2023).","journal-title":"Lancet"},{"key":"4292_CR2","first-page":"CD013829","volume":"8","author":"A Bonney","year":"2022","unstructured":"Bonney, A. et al. Impact of low-dose computed tomography (LDCT) screening on lung cancer-related mortality. Cochrane Database Syst. Rev. 8, CD013829 (2022).","journal-title":"Cochrane Database Syst. Rev."},{"key":"4292_CR3","unstructured":"NHS England National Cancer Programme. Standard Protocol prepared for the Targeted Lung Health Checks Programme (NHS England, 2025); https:\/\/www.england.nhs.uk\/publication\/targeted-screening-for-lung-cancer\/"},{"key":"4292_CR4","unstructured":"National Health Service. England. Targeted Screening for Lung Cancer with Low Radiation Dose Computed Tomography. Quality Assurance Standards prepared for the Targeted Lung Health Checks Programme. Vol. 2025 Version 3 (NHS England, 2025). https:\/\/www.england.nhs.uk\/publication\/targeted-screening-for-lung-cancer\/"},{"key":"4292_CR5","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3310\/hta20400","volume":"20","author":"JK Field","year":"2016","unstructured":"Field, J. K. et al. Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer. Health Technol. Assess. 20, 177 (2016).","journal-title":"Health Technol. Assess."},{"key":"4292_CR6","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1056\/NEJMoa1102873","volume":"365","author":"DR Aberle","year":"2011","unstructured":"Aberle, D. R. et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N. Engl. J. Med. 365, 395\u2013409 (2011).","journal-title":"N. Engl. J. Med."},{"key":"4292_CR7","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.lungcan.2021.09.012","volume":"161","author":"H Balata","year":"2021","unstructured":"Balata, H. et al. Analysis of the baseline performance of five UK lung cancer screening programmes. Lung Cancer 161, 136\u2013140 (2021).","journal-title":"Lung Cancer"},{"key":"4292_CR8","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.lungcan.2019.05.026","volume":"134","author":"B Ghimire","year":"2019","unstructured":"Ghimire, B. et al. Evaluation of a health service adopting proactive approach to reduce high risk of lung cancer: the Liverpool Healthy Lung Programme. Lung Cancer 134, 66\u201371 (2019).","journal-title":"Lung Cancer"},{"key":"4292_CR9","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1136\/thoraxjnl-2017-211377","volume":"74","author":"PA Crosbie","year":"2019","unstructured":"Crosbie, P. A. et al. Implementing lung cancer screening: baseline results from a community-based \u2018Lung Health Check\u2019 pilot in deprived areas of Manchester. Thorax 74, 405\u2013409 (2019).","journal-title":"Thorax"},{"key":"4292_CR10","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1136\/thoraxjnl-2020-214703","volume":"75","author":"M Ruparel","year":"2020","unstructured":"Ruparel, M. et al. Lung Screen Uptake Trial: results from a single lung cancer screening round. Thorax 75, 908\u2013912 (2020).","journal-title":"Thorax"},{"key":"4292_CR11","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.lungcan.2020.07.027","volume":"148","author":"EC Bartlett","year":"2020","unstructured":"Bartlett, E. C. et al. Baseline Results of the West London lung cancer screening pilot study\u2014Impact of mobile scanners and dual risk model utilisation. Lung Cancer 148, 12\u201319 (2020).","journal-title":"Lung Cancer"},{"key":"4292_CR12","unstructured":"Final Report on the Cost-effectiveness of Low Dose Computed Tomography (LDCT) screening for lung cancer in high risk individuals (UK National Screening Committee, 2022)."},{"key":"4292_CR13","unstructured":"Brown, J., Kirk-Wade, E., Baker, C. & Barber, S. Coronavirus: A History of English Lockdown Laws (House of Commons Library, 2021)."},{"key":"4292_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2021.100179","volume":"10","author":"JK Field","year":"2021","unstructured":"Field, J. K. et al. Lung cancer mortality reduction by LDCT screening: UKLS randomised trial results and international meta-analysis. Lancet Reg. Health Eur. 10, 100179 (2021).","journal-title":"Lancet Reg. Health Eur."},{"key":"4292_CR15","unstructured":"Department of Health and Social Care. Independent Investigation of the National Health Service in England (UK Government, 2024)."},{"key":"4292_CR16","unstructured":"NLCA State of the Nation 2025 Version 2 (National Lung Cancer Audit Project, 2025)."},{"key":"4292_CR17","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.21037\/tlcr-20-917","volume":"10","author":"DR Baldwin","year":"2021","unstructured":"Baldwin, D. R., Brain, K. & Quaife, S. Participation in lung cancer screening. Transl. Lung Cancer Res. 10, 1091\u20131098 (2021).","journal-title":"Transl. Lung Cancer Res."},{"key":"4292_CR18","unstructured":"Targeted Lung Health Check programme: Final Evaluation Report (Ipsos UK, 2024)."},{"key":"4292_CR19","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1056\/NEJMoa1211776","volume":"368","author":"MC Tammem\u00e4gi","year":"2013","unstructured":"Tammem\u00e4gi, M. C. et al. Selection criteria for lung-cancer screening. N. Engl. J. Med. 368, 728\u2013736 (2013).","journal-title":"N. Engl. J. Med."},{"key":"4292_CR20","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/S1470-2045(21)00590-8","volume":"23","author":"MC Tammem\u00e4gi","year":"2022","unstructured":"Tammem\u00e4gi, M. C. et al. USPSTF2013 versus PLCOm2012 lung cancer screening eligibility criteria (International Lung Screening Trial): interim analysis of a prospective cohort study. Lancet Oncol. 23, 138\u2013148 (2022).","journal-title":"Lancet Oncol."},{"key":"4292_CR21","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.jtho.2024.12.016","volume":"20","author":"R Gabe","year":"2025","unstructured":"Gabe, R. et al. Prospective evaluation of lung cancer screening eligibility criteria and lung cancer detection in the Yorkshire Lung Screening Trial. J. Thorac. Oncol. 20, 425\u2013436 (2025).","journal-title":"J. Thorac. Oncol."},{"key":"4292_CR22","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.chest.2023.02.003","volume":"164","author":"GA Silvestri","year":"2023","unstructured":"Silvestri, G. A. et al. Outcomes from more than 1 million people screened for lung cancer with low-dose CT imaging. Chest 164, 241\u2013251 (2023).","journal-title":"Chest"},{"key":"4292_CR23","doi-asserted-by":"publisher","first-page":"e008254","DOI":"10.1136\/bmjopen-2015-008254","volume":"5","author":"N Ali","year":"2015","unstructured":"Ali, N. et al. Barriers to uptake among high-risk individuals declining participation in lung cancer screening: a mixed methods analysis of the UK Lung Cancer Screening (UKLS) trial. BMJ Open 5, e008254 (2015).","journal-title":"BMJ Open"},{"key":"4292_CR24","first-page":"CD002834","volume":"9","author":"H Staley","year":"2021","unstructured":"Staley, H. et al. Interventions targeted at women to encourage the uptake of cervical screening. Cochrane Database Syst. Rev. 9, CD002834 (2021).","journal-title":"Cochrane Database Syst. Rev."},{"key":"4292_CR25","doi-asserted-by":"publisher","first-page":"e130","DOI":"10.1016\/S2468-2667(22)00258-4","volume":"8","author":"JL Dickson","year":"2023","unstructured":"Dickson, J. L. et al. Uptake of invitations to a lung health check offering low-dose CT lung cancer screening among an ethnically and socioeconomically diverse population at risk of lung cancer in the UK (SUMMIT): a prospective, longitudinal cohort study. Lancet Public Health 8, e130\u2013e140 (2023).","journal-title":"Lancet Public Health"},{"key":"4292_CR26","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1164\/rccm.201905-0946OC","volume":"201","author":"SL Quaife","year":"2020","unstructured":"Quaife, S. L. et al. Lung Screen Uptake Trial (LSUT): randomized controlled clinical trial testing targeted invitation materials. Am. J. Respir. Crit. Care Med. 201, 965\u2013975 (2020).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"4292_CR27","doi-asserted-by":"publisher","unstructured":"Goodley, P. et al. Population impact of risk-based lung cancer screening on late-stage incidence in Greater Manchester. Lung Cancer Volume. J. Thorac. Oncol. https:\/\/doi.org\/10.1016\/j.jtho.2025.11.014 (2025).","DOI":"10.1016\/j.jtho.2025.11.014"},{"key":"4292_CR28","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1001\/jama.2024.5814","volume":"331","author":"X Feng","year":"2024","unstructured":"Feng, X. et al. Cancer stage compared with mortality as end points in randomized clinical trials of cancer screening: a systematic review and meta-analysis. JAMA 331, 1910\u20131917 (2024).","journal-title":"JAMA"},{"key":"4292_CR29","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1148\/radiol.15142062","volume":"276","author":"C Chiles","year":"2015","unstructured":"Chiles, C. et al. Association of coronary artery calcification and mortality in the National Lung Screening Trial: a comparison of three scoring methods. Radiology 276, 82\u201390 (2015).","journal-title":"Radiology"},{"key":"4292_CR30","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41533-021-00246-8","volume":"31","author":"EC Bartlett","year":"2021","unstructured":"Bartlett, E. C. et al. Implications of incidental findings from lung screening for primary care: data from a UK pilot. npj Primary Care Respir. Med. 31, 36 (2021).","journal-title":"npj Primary Care Respir. Med."},{"key":"4292_CR31","doi-asserted-by":"publisher","first-page":"e004958","DOI":"10.1136\/bmjopen-2014-004958","volume":"4","author":"L Marston","year":"2014","unstructured":"Marston, L. et al. Smoker, ex-smoker or non-smoker? The validity of routinely recorded smoking status in UK primary care: a cross-sectional study. BMJ Open 4, e004958 (2014).","journal-title":"BMJ Open"},{"key":"4292_CR32","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S2213-2600(23)00050-4","volume":"11","author":"W Liao","year":"2023","unstructured":"Liao, W. et al. Predicting the future risk of lung cancer: development, and internal and external validation of the CanPredict (lung) model in 19\u00fa67 million people and evaluation of model performance against seven other risk prediction models. Lancet Respir. Med. 11, 685\u2013697 (2023).","journal-title":"Lancet Respir. Med."},{"key":"4292_CR33","unstructured":"Requirements Specification for Cancer Programme Pilots\u2014Targeted Lung Health Check Pilot (NHS England, 2024)."},{"key":"4292_CR34","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1093\/bjr\/tqae229","volume":"98","author":"AG Taib","year":"2024","unstructured":"Taib, A. G. et al. Quality assurance in lung cancer screening. Br. J. Radiol. 98, 173\u2013179 (2024).","journal-title":"Br. J. Radiol."},{"key":"4292_CR35","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jtho.2023.07.019","volume":"19","author":"S Lam","year":"2023","unstructured":"Lam, S. et al. Current and future perspectives on computed tomography screening for lung cancer: a roadmap from 2023 to 2027 from the International Association for the Study of Lung Cancer. J. Thorac. Oncol. 19, 36\u201351 (2023).","journal-title":"J. Thorac. Oncol."},{"key":"4292_CR36","doi-asserted-by":"publisher","first-page":"ii1","DOI":"10.1136\/thoraxjnl-2015-207168","volume":"70","author":"MEJ Callister","year":"2015","unstructured":"Callister, M. E. J. et al. British Thoracic Society guidelines for the investigation and management of pulmonary nodules: accredited by NICE. Thorax 70, ii1\u2013ii54 (2015).","journal-title":"Thorax"},{"key":"4292_CR37","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/S1470-2045(16)30069-9","volume":"17","author":"JE Walter","year":"2016","unstructured":"Walter, J. E. et al. Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial. Lancet Oncol. 17, 907\u2013916 (2016).","journal-title":"Lancet Oncol."},{"key":"4292_CR38","unstructured":"Implementing a Timed Lung Cancer Diagnostic Pathway (NHS England, 2024)."},{"key":"4292_CR39","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1136\/thoraxjnl-2016-209892","volume":"72","author":"U Yousaf-Khan","year":"2017","unstructured":"Yousaf-Khan, U. et al. Risk stratification based on screening history: the NELSON lung cancer screening study. Thorax 72, 819\u2013824 (2017).","journal-title":"Thorax"},{"key":"4292_CR40","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/S1470-2045(15)00621-X","volume":"17","author":"EF Patz Jr","year":"2016","unstructured":"Patz, E. F. Jr et al. Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial. Lancet Oncol. 17, 590\u2013599 (2016).","journal-title":"Lancet Oncol."},{"key":"4292_CR41","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ije\/dyz076","volume":"49","author":"KE Henson","year":"2019","unstructured":"Henson, K. E. et al. Data Resource Profile: National Cancer Registration Dataset in England. Int. J. Epidemiol. 49, 16\u201316h (2019).","journal-title":"Int. J. Epidemiol."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41591-026-04292-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-026-04292-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-026-04292-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T14:02:56Z","timestamp":1779285776000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41591-026-04292-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["4292"],"URL":"https:\/\/doi.org\/10.1038\/s41591-026-04292-y","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,23]]},"assertion":[{"value":"1 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"H.B. reports honoraria or institutional funding for nonpromotional educational talks or advisory boards from Intuitive Surgical, AMBU, Verathon, ESMO, NICE and OncLive, as well as paid proctorship work with Intuitive Surgical. M.G. has served as a member of the NHS England Screening Advisory Group, the chair of trustees for the British Thoracic Oncology Group and UK Lung Cancer Coalition as a trustee for the Roy Castle Lung Cancer Foundation. R.W.L. is funded by the Royal Marsden NIHR Biomedical Research Centre (BRC) and the Royal Marsden Cancer Charity. R.W.L.\u2019s institution receives compensation for time spent in a secondment role for the NHS England Lung Health Check program and previously as National Specialty Lead for the NIHR. He has received research funding from Cancer Research UK (CRUK), Innovate UK (cofunded by GE HealthCare, Roche Diagnostics, Optellum, Elliptica and RNA Guardian) and SBRI Healthcare (including as a co-applicant with QURE.AI), RM Partners Cancer Alliance and NIHR (including co-applicant in grants with Optellum). He has received honoraria, speaker\/advisory fees, and hospitality\/travel expenses from CRUK, Roche Diagnostics, Johnson & Johnson, Guardant, AstraZeneca and King Faisal Hospital, Saudi Arabia. He also undertakes medical private practice. S.L.Q. is supported by Barts Charity (G-001522, MGU0461) and declares grant income from the NIHR, National Institutes of Health, Yorkshire Cancer Research and CRUK. R.C.R. is funded by Cambridge NIHR BRC (NIHR203312) and CRUK (Cambridge Centre CTRQQR-2021\/100012). He receives research funding from CRUK, UKRI Medical Research Council (MRC), and Asthma and Lung UK. He is a director of and clinical lead for the UK Lung Cancer Coalition. He is a clinical director for the Cambridge and Peterborough Integrated Care System (ICS) Lung Cancer Screening Programme. N.N. is supported by an MRC Clinical Academic Research Partnership (MR\/T02481X\/1). This work was partly undertaken at University College London Hospitals and University College London, which received a proportion of funding from the Department of Health\u2019s NIHR BRC funding scheme. He has received research funding from the NIHR, CRUK, SBRI, UKRI and the Ruth Strauss Foundation. N.N. reports honoraria or institutional funding for nonpromotional educational talks or advisory boards from Amgen, AstraZeneca, AXANA, Boehringer Ingelheim, Bristol Myers Squibb, EQRx, Fujifilm, Guardant Health, Intuitive, Janssen, Lilly, Merck Sharp & Dohme, Olympus, Roche and Sanofi. S.M.J. has received grant income from GRAIL Inc. He is an unpaid member of a GRAIL advisory board. He has received lecture fees for academic meetings from AstraZeneca. His wife works for AstraZeneca. The SUMMIT study is funded by GRAIL through a research grant awarded to S.M.J. as principal investigator. S.M.J. is supported by CRUK program grant no. EDDCPGM\/100002 and an MRC program grant (MR\/W025051\/1\/MRC), the Rosetrees Trust, the Roy Castle Lung Cancer foundation, the Garfield Weston Trust and the UCLH Charitable Foundation. A.R. declares consulting fees from Roche. J.R. was a member of the NHS England screening advisory group and is a member of the UK LC clinical expert group, British Thoracic Oncology Group steering committee, the ELF\/ERS LC task forces and screening groups, the European Organisation for Research and Treatment of Cancer LC group and patient panel, the Cancer research advocates forum, the UCL lung cancer patient and public involvement (PPI) group, the Oxford cancer PPI group, the WM Cancer Alliance LC EAG and advocates\u2019 EAG and BSOL ICS Targeted Lung Health Check working group. She is involved in PPI in several LC studies including PERFormance Evaluation for CT Screening (Nottingham), Lung Impact, DART and DOLCE, which use several industry software programs and tools for lung imaging, including Optellum and QURE AI. She has received occasional honoraria\/travel expenses for LC screening meetings in the UK and Europe. D.R.B. declares grant income from Innovate UK, CRUK, SBRI and Horizon, and lecture honoraria from Boehringer Ingelheim and AstraZeneca. P.C. declares grant income from the NIHR, CRUK, Innovate UK, Yorkshire Cancer Research and Greater Manchester Cancer Alliance, consulting fees from Roche and honoraria from Bayer and Novartis. A.D. reports consulting fees from Boehringer Ingelheim, Roche, AstraZeneca and stocks interests in Brainomix. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}